Membership Benefits
CTA provides a range of benefits to our network members. We are committed to supporting and strengthening the capacity and capability of our members via our key service areas, including:
- Attracting and advocating for clinical trials to be hosted in Australia, specifically within member organisations.
- Developing strategic partnerships within the clinical trials sector to promote and capitalise on member capabilities
- Access to grant writing and management support services
- Centralised feasibility evaluation to facilitate the efficient and timely review of new clinical trials
- Coordination and hosting of quarterly meetings for 11 stream-based Tumour Groups
- Access to clinical trial start-up and ongoing trial administration of ethics and governance activities
- Financial administration of trial activity
CTA Tumour Streams
In 2004, CTA established a range of tumour groups across key tumour types, including; Brain, Breast, Gastro-intestinal, Gynaecology, Haematological Malignancies, Lung, Melanoma, Phase I and Uro-oncology studies. This has since expanded to include Head and Neck as of January 2019.
| Tumour Stream | Tumour Stream Chair |
|---|---|
| Brain | Professor Hui Gan |
| Breast | Dr Belinda Yeo |
| Gastro-intestinal | Dr Margaret Lee |
| Gynaecology | Associate Professor Sumitra Ananda |
| Haematology (Lymphoma/Myeloma) | Professor Michael Dickinson |
| Haematology (Myeloid/AML) | Dr Chun Fong |
| Head and Neck | Professor Danny Rischin |
| Lung | Dr Muhammad Alamgeer |
| Melanoma | Dr George Au-Yeung |
| Phase I/Early Drug Development | Associate Professor Ben Tran |
| Uro-Oncology | Dr Mark Voskoboynik |
Contact Us to discuss becoming part of the CTA Member Network